Baidu
map

Ocul Surf:罗马蜡烛爆炸事故引起的严重眼表损伤的外科治疗

2018-04-01 cuiguizhong MedSci原创

美国辛辛那提大学眼科学系的Cheung AY近日在Ocul Surf发表了一项重要的研究,他们报告了罗马蜡烛爆炸事中眼表损伤患者的临床特征、治疗和结果。

美国辛辛那提大学眼科学系的Cheung AY近日在Ocul Surf发表了一项重要的研究,他们报告了罗马蜡烛爆炸事中眼表损伤患者的临床特征、治疗和结果。

这是一项回顾性、非比较性和介入性病例系列。11名罗马蜡烛爆炸中的眼表受伤患者,在2007年至2016年间在辛辛那提眼科研究所进行跟踪治疗。

11名患者有10名男性和1名女性,平均年龄为22.4岁。单侧眼表损伤程度从看清手指到光感的视敏度。所有患者均有严重的角膜缘干细胞缺乏症,并伴有全眼表面衰竭。8只眼接受了具有角膜基质同种异体移植物(KLAL)的结膜角膜缘自体移植物(CLAU),1只眼接受了具有KLAL的活结膜相关的结膜缘同种异体移植物,并且2只眼接受了具有lr-CLAL的CLAU。其中9只眼进行了后续穿透性角膜移植术,7只眼进行了重建眼睑手术。最后一次随访时有9只眼呈现视力提高的表型,7只眼睛表现出稳定的视角。剩余7例患者有不依从性,或者术后治疗依从性差,或者随访不力。

因此,他们认为,罗马蜡烛相关的事故可能导致严重的眼表损伤。这些眼睛可以在角膜缘干细胞移植和随后的角膜移植术后获得良好的术后视力,并具有良好的依从性。

原文出处:

Cheung, A.Y., et al., Surgical management of severe ocular surface injury due to Roman candle explosion accidents. Ocul Surf, 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1981039, encodeId=49b4198103956, content=<a href='/topic/show?id=5119e290019' target=_blank style='color:#2F92EE;'>#眼表损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72900, encryptionId=5119e290019, topicName=眼表损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac1c235, createdName=tonychen21, createdTime=Tue Jul 31 23:51:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397507, encodeId=3cd0139e507c9, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Apr 03 09:51:00 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301794, encodeId=e0bb301e9432, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 01 20:12:23 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301788, encodeId=c700301e881c, content=牛逼呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88d32315167, createdName=12235fdcm63(暂无昵称), createdTime=Sun Apr 01 19:51:35 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1981039, encodeId=49b4198103956, content=<a href='/topic/show?id=5119e290019' target=_blank style='color:#2F92EE;'>#眼表损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72900, encryptionId=5119e290019, topicName=眼表损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac1c235, createdName=tonychen21, createdTime=Tue Jul 31 23:51:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397507, encodeId=3cd0139e507c9, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Apr 03 09:51:00 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301794, encodeId=e0bb301e9432, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 01 20:12:23 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301788, encodeId=c700301e881c, content=牛逼呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88d32315167, createdName=12235fdcm63(暂无昵称), createdTime=Sun Apr 01 19:51:35 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1981039, encodeId=49b4198103956, content=<a href='/topic/show?id=5119e290019' target=_blank style='color:#2F92EE;'>#眼表损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72900, encryptionId=5119e290019, topicName=眼表损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac1c235, createdName=tonychen21, createdTime=Tue Jul 31 23:51:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397507, encodeId=3cd0139e507c9, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Apr 03 09:51:00 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301794, encodeId=e0bb301e9432, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 01 20:12:23 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301788, encodeId=c700301e881c, content=牛逼呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88d32315167, createdName=12235fdcm63(暂无昵称), createdTime=Sun Apr 01 19:51:35 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
    2018-04-01 天地飞扬

    了解一下.谢谢分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1981039, encodeId=49b4198103956, content=<a href='/topic/show?id=5119e290019' target=_blank style='color:#2F92EE;'>#眼表损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72900, encryptionId=5119e290019, topicName=眼表损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac1c235, createdName=tonychen21, createdTime=Tue Jul 31 23:51:00 CST 2018, time=2018-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397507, encodeId=3cd0139e507c9, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Apr 03 09:51:00 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301794, encodeId=e0bb301e9432, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 01 20:12:23 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301788, encodeId=c700301e881c, content=牛逼呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=88d32315167, createdName=12235fdcm63(暂无昵称), createdTime=Sun Apr 01 19:51:35 CST 2018, time=2018-04-01, status=1, ipAttribution=)]
    2018-04-01 12235fdcm63(暂无昵称)

    牛逼呀

    0

Baidu
map
Baidu
map
Baidu
map